Lam Research (NASDAQ:LRCX) Trading Up 1.7% on Analyst Upgrade

Shares of Lam Research Corporation (NASDAQ:LRCX) traded up 1.7% during trading on Wednesday after Barclays raised their price target on the stock from $250.00 to $255.00. Barclays currently has an equal weight rating on the stock. Lam Research traded as high as $221.62 and last traded at $218.87. 7,128,309 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 12,210,447 shares. The stock had previously closed at $215.23.

LRCX has been the topic of several other research reports. Mizuho set a $265.00 price objective on shares of Lam Research in a research report on Wednesday, January 28th. HSBC upped their target price on shares of Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday, December 29th. Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $320.00 price objective (up from $265.00) on shares of Lam Research in a report on Thursday, January 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.

Insider Buying and Selling at Lam Research

In other Lam Research news, insider Ava Harter sold 4,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.50, for a total value of $930,000.00. Following the completion of the sale, the insider owned 54,705 shares in the company, valued at approximately $12,718,912.50. This trade represents a 6.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director owned 253,705 shares in the company, valued at approximately $57,235,848. This represents a 12.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 130,886 shares of company stock valued at $29,658,802 in the last 90 days. Insiders own 0.31% of the company’s stock.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Long‑term collaboration with IBM to advance sub‑1nm logic scaling — strengthens Lam’s position on next‑generation logic and EUV-related process work, expanding addressable content per wafer fab cycle. IBM and Lam Research Announce Collaboration to Advance Sub‑1nm Logic Scaling
• Positive Sentiment: S&P 100 inclusion, recent strong results and supportive market notes should boost demand — index addition and re‑rating flows plus solid Jan quarter results and guidance increase passive and active buying pressure. Lam Research jumps amid semiconductor-equipment rebound and S&P 100 addition
• Positive Sentiment: Industry capex outlook remains strong — banks raised chip‑gear spending estimates and analyst notes point to sustained WFE upside, supporting equipment vendors like Lam. Chip Gear Spending Shows No Signs Of Slowing
• Positive Sentiment: Short interest in LRCX fell meaningfully in February (≈20.7% decline), reducing immediate short‑squeeze risk and removing some downward pressure on the shares.
• Positive Sentiment: Analyst support and higher price targets remain widespread (median targets above current levels; Barclays nudged its PT higher), providing additional directional support. Barclays raises LRCX price target
• Neutral Sentiment: Independent equity research continues to highlight a favorable WFE cycle and Lam’s potential for share gains — useful context for medium‑term investors but not an immediate catalyst. Lam Research: The Setup Keeps Getting Stronger
• Negative Sentiment: Hazeltree reports hedge funds ramping short bets amid geopolitical and private‑credit concerns — broader market volatility and flow shifts could pressure cyclicals like Lam in risk‑off episodes. Hazeltree Finds Hedge Funds Ramp Up Short Bets
• Negative Sentiment: Notable insider selling activity reported across senior executives over the past six months — raises a governance/optics flag for some investors and can weigh on sentiment. Quiver Quant on LRCX insider activity

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. PMV Capital Advisers LLC purchased a new stake in Lam Research in the fourth quarter worth about $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the 3rd quarter worth approximately $26,000. Bayban bought a new position in shares of Lam Research in the 4th quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the 2nd quarter worth approximately $27,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the 3rd quarter valued at approximately $27,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Trading Up 1.7%

The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The company has a market cap of $273.32 billion, a PE ratio of 44.85, a PEG ratio of 2.32 and a beta of 1.77. The stock has a 50 day moving average price of $223.44 and a 200 day moving average price of $171.66.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. The firm’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s payout ratio is presently 21.31%.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.